CAPPED BONUSZERTIFIKAT - CARL ZEISS MEDITEC Share Price

Certificat

DE000PC66BY8

Market Closed - Börse Stuttgart 09:23:42 16/05/2024 BST
78.07 EUR +0.30% Intraday chart for CAPPED BONUSZERTIFIKAT - CARL ZEISS MEDITEC
Current month+0.50%
1 month-0.42%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
16/05/24 78.07 +0.30%
15/05/24 77.84 +1.41%
14/05/24 76.76 -0.25%
13/05/24 76.95 -1.23%
10/05/24 77.91 +1.12%

Delayed Quote Börse Stuttgart

Last update May 16, 2024 at 09:23 am

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying CARL ZEISS MEDITEC AG
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC66BY
ISINDE000PC66BY8
Date issued 25/03/2024
Strike 90
Maturity 19/12/2025 (582 Days)
Parity 1 : 1
Emission price 78.27
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 81.46
Lowest since issue 76.64
Spread 0.68
Spread %0.86%

Company Profile

Carl Zeiss Meditec AG is a Germany-based medical technology and device company. It offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment comprises activities in the area of ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose and throat surgery, as well as the activities in the field of intraoperative radiation. The Company has various production sites in Europe, the United States and Asia.
Sector
-
More about the company

Ratings for Carl Zeiss Meditec AG

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Carl Zeiss Meditec AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
96.85 EUR
Average target price
105.5 EUR
Spread / Average Target
+8.97%
Consensus